Symbols

RXST

RxSight·NASDAQ

--(--)

RXST fundamentals

RXST Q4 2025 Earnings

RxSight (RXST) released its earnings on Feb 25, 2026: revenue was 32.61M (YoY -18.92%), beat estimates; EPS was -0.22 (YoY -46.67%), beat estimates.

Revenue / YoY

32.61M

-18.92%

EPS / YoY

-0.22

-46.67%

Report date

Feb 25, 2026

RXST Earnings Call Summary for Q4,2025

Revenue decline: Q4 2025 sales down 19% YoY to $32.6M, driven by LDD decline. LAL sales grew 12% to $28.2M, accounting for 86% of revenue.
Gross margin improvement: 77.5% (vs. 71.6% YoY) due to higher LAL mix. 2026 gross margin guided to 70-72% due to inventory costs.
Installed base growth: 1,134 LDDs (+17% YoY). LAL utilization improved sequentially, with 10% U.S. premium market penetration.
2026 guidance: Revenue $120M-$135M (-5% midpoint). Q1 2026 expected to be weakest due to tough comps, with sequential improvement in Q2+.
International expansion: Early-stage efforts in Europe, Asia, and Australia. Japan and China approvals pending.

Earnings

EPS

Revenue

Revenue & Expenses

RXST has released its 2025 Q4 earnings report, with revenue of 32.61M, reflecting a YoY change of -18.91%, and net profit of -9.15M, showing a YoY change of -54.13%. The Sankey diagram below clearly presents RXST's revenue sources and cost distribution.

Key Indicators

RxSight (RXST) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

RxSight (RXST)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

RxSight (RXST)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

RxSight (RXST)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown